Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Bio-Rad signs collaboration agreement with Caliper to investigate microfluidic system.


Bio-Rad Laboratories, Inc. (Hercules, CA) and Caliper caliper

Instrument that consists of two adjustable legs or jaws for measuring the dimensions of material parts. Spring calipers have an adjusting screw and nut; firm-joint calipers use friction at the joint to hold the legs unmoving.
 Life Sciences, Inc. (Hopkinton, MA) formed a collaboration under which the companies will study the feasibility of developing a new microfluidics system platform. Details of the new product concept are not being disclosed at

this time. The two companies' previous collaboration, initiated in mid-2003, resulted in the successful launch of a new microfluidics-based electrophoresis electrophoresis (ĭlĕk'trōfərē`sĭs): see colloid.
electrophoresis

Movement of electrically charged particles in a fluid under the influence of an electric field.
 product, Experion, in the fall of 2004.

"The success we've enjoyed with the Experion Automated au·to·mate  
v. au·to·mat·ed, au·to·mat·ing, au·to·mates

v.tr.
1. To convert to automatic operation: automate a factory.

2.
 Electrophoresis System has confirmed our belief that microfluidics is a key strategic technology," commented Norman Schwartz, president and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  at Bio-Rad. "After our first positive experience collaborating with Caliper, we are looking forward to this next collaboration where we will pursue new ideas "New Ideas" is the debut single by Scottish New Wave/Indie Rock act The Dykeenies. It was first released as a Double A-side with "Will It Happen Tonight?" on July 17, 2006. The band also recorded a video for the track.  regarding LabChip microfluidics as the foundation for innovative new products."

Kevin Hrusovsky, Caliper's president and CEO, also commented, "Bio-Rad is a model partner for our 'Caliper Driven' program, under which we enable life science companies like Bio-Rad to tap into our innovative technologies, expertise and patent portfolio. Their strong reputation in life sciences and diagnostics, and their well-established global distribution very effectively leverage our technology into key markets."

Bio-Rad is a multinational manufacturer and distributor of life science research products and clinical diagnostics. It is based in Hercules, California Hercules is a city in Contra Costa County, California, United States. The population was 19,488 at the 2000 census. It is one of many small “bedroom communities” along the I-80 corridor in Western Contra Costa County. , and serves thousands of research and industry customers worldwide through a network of more than 30 wholly owned subsidiary Wholly Owned Subsidiary

A subsidiary whose parent company owns 100% of its common stock.

Notes:
In other words, the parent company owns the company outright and there are no minority owners.
 offices.

Caliper uses its leading microfluidics patent estate, innovative automation technologies, and broad assay expertise to accelerate drug discovery, enable diagnosis of disease and facilitate scientific research. With the acquisition of NovaScreen Biosciences in October 2005, Caliper became the first company to provide a comprehensive, central resource for drug discovery products and services.

Caliper Life Sciences

+1-650-279-2088

www.caliperls.com

Bio-Rad Laboratories, Inc.

+1-510-741-6063

www.bio-rad.com
COPYRIGHT 2005 Biotech Patent News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:BIOTECH Patent News
Geographic Code:1USA
Date:Oct 1, 2005
Words:294
Previous Article:Forest and Lundbeck announce Lexapro patent litigation trial date rescheduled.
Next Article:iCAD collaborates with George Washington University to bring digital breast cancer screening to D.C.
Topics:



Related Articles
Bio-rad enters microfluidic market with Caliper's help. (Executive briefing: news, trends & market intelligence for instrument executives).
Bio-Rad set to acquire MJ Research.
Bio-Rad buys MJ GeneWorks.
Virtek and Bio-Rad Settle microarray dispute.
BioSource rebuffs Bio-Rad's unsolicited offer.
Endpoint: Bio-Rad.
Bio-Rad announces receipt of ruling in aApplied Biosystems patent infringement dispute.
Bio-Rad and SELDI.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles